ACTalks Blogs

 View Only

Message from ACT Corporate Partner — Altasciences

By Art Shaw posted 09-27-2023 03:00 PM

  
ACT Corporate Partner Message 


Altasciences―A Different Kind of CRO/CDMO
Applications of Miniature Swine in Small and Large Molecule Nonclinical Studies
The use of miniature swine beyond dermal and wound healing research has grown in recent years due to their availability, anatomical similarities to humans, and lower cost compared to other non-rodent models. With greater characterization of the miniature swine model, increased historical data, and wider regulatory acceptance, this species is well-positioned to replace standard non-rodent species in many safety assessment programs.
Altasciences has extensive knowledge and experience in GLP and non-GLP studies, with small molecules and biologics, using a range of miniature swine breeds. We have conducted over 300 studies in several therapeutic and research areas, including dermal, metabolic, inflammation, oncology, CNS disorders, ocular diseases, and HIV. Our veterinary surgeons and scientists combine their skills in various modalities, molecules, and disease indications to support the development of your novel drug candidates.
Learn more about Altasciences’ experience and discover how miniature swine can be an advantageous option for your toxicology and pharmacology studies.
Is miniature swine the right model for your project? Let’s discuss at Booth #207.
To discover our comprehensive preclinical services, visit altasciences.com.
0 comments
43 views

Permalink